Wellington Management Group LLP Medi Wound Ltd. Transaction History

Wellington Management Group LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.34 - $4.63 $641,680 - $889,515	-192,120 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.38 - $5.71 $43,476 - $73,447	-12,863 Reduced 6.28%	192,120 $736,000
Q1 2021 May 17, 2021	SELL	$3.77 - $6.05 $519,340 - $833,423	-137,756 Reduced 40.19%	204,983 $1.1 Million
Q4 2020 Feb 12, 2021	SELL	$3.12 - $4.08 $51,411 - $67,230	-16,478 Reduced 4.59%	342,739 $1.27 Million
Q3 2020 Nov 16, 2020	BUY	$3.09 - $4.14 $4,251 - $5,696	1,376 Added 0.38%	359,217 $1.35 Million

Q2 2020 Aug 14, 2020	SELL	$1.47 - $2.97 $3.02 Million - $6.11 Million	-2,056,593 Reduced 85.18%	357,841 $1.06 Million
Q1 2020 May 14, 2020	SELL	$1.57 - $3.1 $621,850 - $1.23 Million	-396,083 Reduced 14.09%	2,414,434 $3.79 Million
Q4 2019 Feb 11, 2020	BUY	$2.72 - $3.15 $7.64 Million - $8.85 Million	2,810,517 New	2,810,517 $8.71 Million

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $789M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.